BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28322887)

  • 1. Staphylococcus aureus bacteremia in patients with rheumatoid arthritis - Data from the prospective INSTINCT cohort.
    Joost I; Kaasch A; Pausch C; Peyerl-Hoffmann G; Schneider C; Voll RE; Seifert H; Kern WV; Rieg S
    J Infect; 2017 Jun; 74(6):575-584. PubMed ID: 28322887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for
    Dieperink SS; Glintborg B; Oestergaard LB; Nørgaard M; Benfield T; Mehnert F; Petersen A; Hetland ML
    BMJ Open; 2019 Sep; 9(9):e030999. PubMed ID: 31481566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus bloodstream infection in patients with ventricular assist devices-Management and outcome in a prospective bicenter cohort.
    Joost I; Bothe W; Pausch C; Kaasch A; Lange B; Peyerl-Hoffmann G; Flüh G; Müller M; Schneider C; Seifert H; Kern WV; Beyersdorf F; Rieg S
    J Infect; 2018 Jul; 77(1):30-37. PubMed ID: 29778631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
    Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy.
    Goodman SM; Nocon AA; Selemon NA; Shopsin B; Fulmer Y; Decker ME; Grond SE; Donlin LT; Figgie MP; Sculco TP; Russell LA; Henry ME; Bass AR; Miller AO; Sculco PK
    J Arthroplasty; 2019 May; 34(5):954-958. PubMed ID: 30733073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of
    Gompelman M; Tuinte RAM; Berrevoets MAH; Bleeker-Rovers CP; Wanten GJA
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066383
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients.
    Rieg S; Joost I; Weiß V; Peyerl-Hoffmann G; Schneider C; Hellmich M; Seifert H; Kern WV; Kaasch A
    Clin Microbiol Infect; 2017 Jun; 23(6):406.e1-406.e8. PubMed ID: 27615722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
    Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
    J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
    Lalani T; Boucher HW; Cosgrove SE; Fowler VG; Kanafani ZA; Vigliani GA; Campion M; Abrutyn E; Levine DP; Price CS; Rehm SJ; Corey GR; Karchmer AW;
    J Antimicrob Chemother; 2008 Jan; 61(1):177-82. PubMed ID: 17999973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
    Trials; 2015 Oct; 16():450. PubMed ID: 26452342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.
    López-Cortés LE; Gálvez-Acebal J; Del Toro MD; Velasco C; de Cueto M; Caballero FJ; Muniain MA; Pascual A; Rodríguez-Baño J
    PLoS One; 2013; 8(12):e82958. PubMed ID: 24376617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Analysis in 2 Large, Prospectively Evaluated Cohorts.
    Camp J; Glaubitz L; Filla T; Kaasch AJ; Fuchs F; Scarborough M; Kim HB; Tilley R; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Llewelyn M; Fowler VG; Thwaites G; Seifert H; Kern WV; Kuss O; Rieg S
    Clin Infect Dis; 2021 Oct; 73(7):1239-1247. PubMed ID: 33914861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortality.
    Perez-Jorge EV; Burdette SD; Markert RJ; Beam WB
    J Hosp Med; 2010 Apr; 5(4):208-11. PubMed ID: 20394025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus bacteremia.
    Jensen AG
    Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortality.
    Pulcini C
    J Hosp Med; 2010; 5(6):E11. PubMed ID: 20803664
    [No Abstract]   [Full Text] [Related]  

  • 18. Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failure.
    Jung N; Ernst A; Joost I; Yagdiran A; Peyerl-Hoffmann G; Grau S; Breuninger M; Hellmich M; Kubosch DC; Klingler JH; Seifert H; Kern WV; Kaasch AJ; Rieg S
    J Infect; 2021 Sep; 83(3):314-320. PubMed ID: 34146597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia.
    Kinamon T; Dagher M; Park L; Ruffin F; Fowler VG; Maskarinec SA
    Clin Infect Dis; 2023 Nov; 77(9):1226-1233. PubMed ID: 37747828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.
    Kaasch AJ; Rieg S; Kuetscher J; Brodt HR; Widmann T; Herrmann M; Meyer C; Welte T; Kern P; Haars U; Reuter S; Hübner I; Strauss R; Sinha B; Brunkhorst FM; Hellmich M; Fätkenheuer G; Kern WV; Seifert H;
    Infection; 2013 Oct; 41(5):979-85. PubMed ID: 23539143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.